头孢氨苄片(Uyalecini Tabeillae),是美国Lilly公司于1967年研制成功的半合成广谱口服抗生素。继而在英、法、瑞、西德等国陆续大量上市,1973年英国Glaxo公司销售头孢氨苄占世界销售头孢菌素总额的30％,1978年日本生产头孢氨苄量属世界首位。头孢氨苄系细菌繁殖期杀菌剂,能抑制其生化合成,迅速溶解。对革兰氏阳性及阴性菌有强烈的杀菌作用。主治肾炎、肾盂肾炎、尿道炎、膀胱炎、前列腺炎、气管 Cefalexin tablets (Uyalecini Tabeillae), is the United States Lilly company in 1967 successfully developed semi-synthetic broad-spectrum oral antibiotics. Then in Britain, France, Switzerland, West Germany and other countries after another large number of listed in 1973 Glaxo company sales of cephalexin accounted for 30% of the world sales of cephalosporins in 1978, Japan’s production of cephalexin is the world’s first volume. Cefalexin Bacteria germicide bactericide, can inhibit its biochemical synthesis, rapid dissolution. Gram-positive and negative bacteria have a strong bactericidal effect. Indications nephritis, pyelonephritis, urethritis, cystitis, prostatitis, trachea